A B S T R A C T A new method for relating regional intravascular resistance to pulmonary arterial, capillary, and venous pressure and volume was used to evaluate local differences of reactivity in the pulmonary blood vessels in the isolated lung lobe of the dog. 
INTRODUCTION
Measurements of pulmonary arterial, capillary, and venous responses to stimuli that affect the Dr. Brody is a postdoctoral fellow of the National Institutes of Health.
Received for publication 11 September 1967 and in revised form 4 December 1967. pulmonary circulation have been limited by technical difficulties inherent in the determination of intravascular pressure at points throughout the pulmonary vascular bed. In the preceding paper (1), we described a method for determining the longitudinal distribution of vascular resistance in the lung. This method, based on a principle described by Piiper (2) , provides a way of determining pressure and resistance to blood flow throughout the pulmonary vascular bed without requiring direct pressure measurements from multiple points within the lung vessels.
The present study was undertaken to determine if the methods described could be used to measure the differential reactivity of the pulmonary arteries, capillaries, and veins. Measurements of lobar pulmonary artery or vein volume, total lobar blood volume, and the volume to the midpoint of lobar vascular resistance were made in the dog isolated lung lobe before and during infusion of isoproterenol, serotonin, or histamine into the vascular inflow of the lobe. Measurements made during a control period and during drug infusion were compared, and arterial, capillary, and venous responses to the drugs were analyzed.
METHODS
The details of the methods used and the principles involved in this study are described in the preceding paper (1) .
In seven dogs weighing 10-14 kg, the left basal lobe was removed, placed in an airtight Plexiglas box, and perfused at constant flow with blood drawn from a heparinized donor dog. The blood, warmed to 37'C, flowed through the lung into a constant pressure reservoir which was set to maintain downstream vascular pressure at about 10 cm H20, and was drained from this reservoir by gravity back into the donor dog. The isolated lobe was ventilated with room air by a positive pressure respirator with a con-stant stroke volume set to produce transpulmonary pressures of 8-10 cm H20 at peak inspiration. End Resistivity decreased throughout the pulmonary vascular bed (Fig. 2) .
Serotonin. During forward perfusion, 1.5 jug/ min per kg of serotonin (low dose) caused a 51 % increase in vascular resistance. The midpoint of vascular resistance moved forward into the pulmonary artery signifying a relative increase in arterial resistance. Mean arterial distending pressure increased 21%o, but arterial volume decreased 21 %o, and arterial conductance decreased 44%o.
The changes in the capillaries and veins were too small to be regarded as significant. Resistivity (Fig. 2) increased markedly in both the large and small pulmonary arteries but remained unchanged in the capillaries and veins. The arteries accounted for 52% of total vascular resistance before and 67%o of vascular resistance during serotonin infusion.
In (Fig. 2) increased markedly in the veins and to a lesser extent in the early downstream vessels. Venous resistance increased from 20% to 31% of lobar vascular resistance.
Transpulmonary pressure (bronchial pressure -plethysmograph pressure) for a given inspired volume was unchanged during isoproterenol and serotonin infusion. During histamine infusion transpulmonary pressure rose about 20%o. There was no gross evidence of air-trapping, and since all measurements were made at an end expiratory pressure of 3-5 cm H2O, bronchoconstriction should not have affected the results.
There were no significant changes in Po2, Pco2, or pH of the blood flowing into the lobe during infusion of any of the drugs. The amount of ether evolved did not change during drug infusion which suggests that gross pulmonary edema did not occur (3) . DISCUSSION The resistance to blood flow through a vessel is dependent on the tensions that develop in the vessel wall and on the pressure distending the vessel. Wall tension may change as a result of nervous stimulation and alterations in the cotnposition of inflow blood or alveolar gas. Vascular distending pressure is dependent on the rate of blood flow and on downstream ("left atrial") pressure. In the present experiments blood and alveolar gas tensions were held constant, and nervous connections were severed. Blood flow and "left atrial" pressure were constant. Therefore, the alterations in vascular resistance measured resulted from changes in vascular tone induced by the drugs and changes in vascular distending pressure, both dependently associated.
Shifts in the midpoint of vascular resistance give a general picture of the predominant changes in vascular resistance that occurred after drug infusion. Changes in arterial and downstream volume and venous and downstream volume provide further information about individual vascular responses. But only by calculating resistance and pressure throughout the pulmonary blood vessels and relating intravascular distending pressure to the individual vascular volumes could an accurate analysis of vessel response be made.
Isoproterenol. Isoproterenol caused active vasodilation in all of the pulmonary vessels without altering the longitudinal distribution of vascular resistance. Resistivity decreased throughout the pulmonary vascular bed during both forward and reverse perfusion. During forward perfusion arterial distending pressure deceased, but arterial volume and conductance increased. This phenomenon can only be explained by active arterial vasodilation. A similar pattern was present in downstream (combined capillary and venous) vessels. During reverse perfusion venous distending pressure decreased, whereas venous volume and conductance increased. This is the picture of active vasodilation. The capillary and arterial vessels responded in the same fashion.
The increase in arterial and venous conductance can be explained by relaxation of vascular smooth muscle, but the explanation for the apparent increase in capillary conductance is not clear. If the capillaries reacted in a purely passive fashion, capillary volume and conductance should have decreased because of the lower downstream distending pressure in the veins (forward perfusion) or the arteries (reverse perfusion). The absence of contractile cells around the capillaries or smooth muscle in the capillary walls makes it unlikely that the individual capillaries could contract or dilate actively (7) . The apparent active dilation of the capillary bed might be explained by the opening of capillary vessels distal to arterioles (forward perfusion) or venules (reverse perfusion) which dilated in response to isoproterenol. This type of response is supported by the studies of Wearn, Ernstone, Bromer, Barr, German, and Zschiesche (8) who observed intermittence of blood flow in the pulmonary capillaries as a result of vasomotor changes in the arterioles.
These results indicate that both arteries and veins are capable of constriction in the isolated lobe preparation. Since isoproterenol decreased resistance in arteries and veins but did not markedly alter the longitudinal distribution of vascular resistance in the lobe, it appears that mechanical factors such as vascular distending pressure rather than vasomotor tone are the most important determinants of the resistance to blood flow in the isolated lung. Most investigators have found that isoproterenol causes vasodilation in the pulmonary circulation (8, 9) . We are unaware, however, of any other studies of the specific pulmonary vessels affected by isoproterenol.
Serotonin. Serotonin caused active constricttion of both the pulmonary arteries and veins. During forward perfusion pulmonary artery volume and conductance decreased despite an increase in distending pressure. Both large and small arteries must have constricted because there were large changes in conductance (predominantly attributable to small arteries) and volume (predominantly attributable to large arteries). There was little or no measurable change in the remainder of the vascular bed. A high dose of serotonin caused additional arterial vasoconstriction and a definite decrease in downstream conductance and volume.
During reverse perfusion a low dose of serotonin caused generalized vasoconstriction in the pulmonary veins. There was a slight increase in downstream resistivity and decrease in capillary and artery conductance presumably as a result of arterial constriction. Capillary and artery volume inceased probably as a result of capillary distention caused by constriction of the arterial vessels. A high dose of serotonin caused further venous constriction and rather marked downstream vasoconstriction. The increase in capillary resistivity and large capillary and artery volume change may have resulted from closure of capillaries distal to markedly constricted small veins, a mechanism operating in the opposite direction of that proposed with isoproterenol infusion.
Low doses of serotonin caused active constriction of whichever vessels were upstream, arteries or veins. High doses produced significant constriction of downstream vessels as well. These findings suggest that the environment of the downstream vessels altered the threshold of response to serotonin, or that the concentration of the serotonin in the downstream vessels was less than that in the upstream vessels. The latter possibility is supported by the work of Gaddum, Hebb, Silver and Swan (10) who showed that 20% of injected serotonin can be metabolized in one passage through the isolated lung. Recently Davies and Wang (11) found similar rapid inactivation of serotonin in the intact lung. It is possible that pulmonary metabolism of other drugs may alter downstream vascular responses. Eiseman, Bryant, and Waltuch (12) have shown that norepinephrine, acetylcholine, and serotonin, but not histamine, are metabolized in the isolated lung.
Although it is generally agreed that serotonin causes pulmonary vasoconstriction (8, 13) , there is no consensus about which vessels in the lung serotonin affects. Several studies have shown venous constriction (14, 15) , whereas others have found predominant arterial constriction (16, 17) . Our findings help explain many of the seemingly conflicting results in the literature.
Histamine. Histamine caused predominantly active venous constriction, but changes also occurred in capillary and arterial vessels. During forward perfusion the major response to histamine was in the downsteam vessels. Resistivity increased throughout the capillary and venous vessels, and capillary and venous conductance and volume decreased. The increased intravascular distending pressure transmitted to the lobar arteries caused no change in arterial conductance or volume. If the arteries had responded in a purely passive fashion arterial volume should have increased 10-15% (18) . The lack of volume change suggests that there may have been a slight increase in arterial tone which countered the increased distending pressure.
The increased capillary resistivity cannot be explained by closing of capillaries distal to constricted upstream arterial vessels, since these vessels constricted only slightly. Histamine produces an increase in capillary permeability in systemic vessels, probably as a direct action on the capillary wall (19, 20) . Such an increase in pulmonary capillary permeability could lead to interstitial fluid accumulation in the pericapillary spaces with compression of the capillary vessels and decrease in capillary volume and conductance.
Reverse perfusion experiments support the above hypothesis. Active venous constriction of Pulmonary Vascular Reactivityboth large and small vessels predominated. Capillary resistivity increased, possibly as a result of pericapillary edema. Total capillary and artery conductance increased slightly. This increase could be explained by large artery constriction producing an increase in small artery distending pressure with a passive increase in small artery volume and conductance.
There is rather general agreement that histamine causes predominant pulmonary venous constriction (8, 21) , but associated arterial constriction has been found by some investigators (13) . The effect of histamine on the pulmonary capillary vessels has not previously been investigated.
